Latest News about pfe
Recent news which mentions pfe
Is It Time to Buy the S&P 500's 3 Worst-Performing January Stocks?
February 03, 2023
From Motley Fool
Got $1,000? 3 Cheap Stocks To Buy Right Now
February 02, 2023
From Motley Fool
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
February 02, 2023
From Motley Fool
Tickers
PFE
From Motley Fool
AMD To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Wednesday
February 01, 2023
From Benzinga
S&P 500 Jumps 1.5%, Market Volatility Decreases
February 01, 2023
From Benzinga
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
From Motley Fool
Dow Surges Over 200 Points; Pfizer Issues Weak Forecast
January 31, 2023
From Benzinga
From MarketWatch
Waiting for Powell: As Fed Meeting Starts, Investors Parse Mixed Q4 Earnings and Consider What's Next for Rates
January 31, 2023
From Benzinga
From Benzinga
Biden to end U.S. COVID emergencies on May 11, but more than 500 people are still dying every day
January 31, 2023
Tickers
PFE
Tags
PFE
From MarketWatch
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
From Benzinga
Most Important Week Of Earnings Season Is Here — Will S&P 500 Companies Continue Beating Wall Street Estimates?
January 31, 2023
From Benzinga
From Benzinga
Pfizer Beats Q4 Earnings, Issues Underwhelming 2023 Guidance
January 31, 2023
Tickers
PFE
From Benzinga
4 Discounted Dividend Stocks To Buy In February 2023
January 31, 2023
From Motley Fool
This newsletter editor has been recommending stocks and bonds this year and says the rally has room to run
January 31, 2023
From MarketWatch
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
January 31, 2023
From Benzinga
Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times
January 31, 2023
From Benzinga
Earnings Scheduled For January 31, 2023
January 31, 2023
From Benzinga
From Benzinga
Investor Optimism Declines Ahead Of Fed's Rate Decision
January 31, 2023
From Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
From InvestorPlace
Down 14.5%, Is Pfizer Stock a Screaming Buy?
January 30, 2023
From Motley Fool
Volatility Test: VIX Makes an Early Move Higher as Stocks Slide Ahead of Manic Market Week
January 30, 2023
From Benzinga
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.